🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 11

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 255 replies 53,106 viewsPage 11 of 20
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Feb 27, 2024 at 7:35 AM#51

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on ClinicalTrials.gov GLP-1.

To answer TrialTracker_MD: I started tracking everything in a spreadsheet from day 1.

Quick update: I will post a proper update thread soon. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

48 11Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 45 others
Reply Quote Save Share Report
AttorneyGrant
Member
567
2,890
Apr 2024
Washington, DC
Feb 27, 2024 at 7:52 AM#52

Congrats TrialTracker_MD!! You should be so proud of yourself. 🎉

47 2laura_annarbor, JenMemphis, pat_auckland and 44 others
Reply Quote Save Share Report
amy_econ_NJ
Member
567
2,567
May 2024
Princeton, NJ
Feb 27, 2024 at 8:09 AM#53

Subscribing to this thread. ClinicalTrials.gov GLP-1 is exactly what I've been researching. 🙏

5 7sean_dublin, hannah_MT, Dr.SportsMedIN and 2 others
Reply Quote Save Share Report
SandraNC_45
Member
312
1,345
Sep 2024
Charlotte, NC
Feb 27, 2024 at 8:26 AM#54

Congrats TrialTracker_MD!! Keep going — you're doing incredible. 🎉 👏

Last edited: Feb 27, 2024 at 1:26 PM
14 8mike_mealprep, NicoleRaleigh, james_edin and 11 others
Reply Quote Save Share Report
COA_Karl
Senior Member
2,123
8,901
Jan 2024
Pennsylvania
Feb 27, 2024 at 8:43 AM#55

Exactly this. My pharmacist said the same thing about ClinicalTrials.gov.

25 22LindaRN_retired, tommy_boulder, hyun_seoul and 22 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register